Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3360-3367

  Henderson Jr , William R ^a   Lu, Jiangyang ^a,c   Poole, Karen M ^b   Dietsch, Gregory N ^b   Chi, Emil Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c 304TH HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BLOOD VESSEL PERMEABILITY; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME DEGRADATION; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION; LUNG LAVAGE; MEDIATOR RELEASE; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RESPIRATORY TRACT INFECTION;

EID: 0343484308     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3360     Document Type: Article

References (64)

1. Henderson, W. R., Jr. 1991. Eicosanoids and platelet-activating factor in allergic-respiratory diseases. Am. Rev. Respir. Dis. 143:S86.
2. Prescott, S. M., G. A. Zimmerman, and T. M. McIntyre. 1990. Platelet-activating factor. J. Biol. Chem. 265:17381.
3. Camussi, G., I. Pawlowski, and C. Tetta. 1983. Acute lung inflammation induced in the rabbit by local instillation of 1-O-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or native platelet activating factor. Am. J. Pathol. 112:78.
4. O'Connor, B. J., S. Uden, T. J. Carty, J. D. Eskra, P. J. Barnes, and K. F. Chung. 1994. Inhibitory effect of UK74505, a potent and specific oral platelet activating factor (PAF) receptor antagnoist, on airway and systemic responses to inhaled PAF in humans. Am. J. Respir. Crit. Care Med. 150:35.
5. Hahn, H. L., I. Purnama, M. Lang, and U. Sannwald. 1986. Effects of platelet-activating factor on tracheal mucus secretion, on airway mechanics and on circulating blood cells in live ferrets. Eur. J. Respir. Dis. 146:277.
6. Lang, M., D. Hansen, and H. L. Hahn. 1987. Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. Agents Actions 21:245.
7. Wedmore, C. V., and T. J. Williams. 1981. Platelet activating factor (PAF), a secretory product of polymorphonuclear leukocytes, increases vascular permeability in rabbit skin. Br. J. Pharmacol. 74:916.
8. Humphrey, D. M., L. M. McManus, K. Satouchi, D. J. Hanahan, and R. N. Pinckard. 1982. Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. Lab. Invest. 46:422.
9. Pirotzky, E., C. P. Page, R. Roubin, A. Pfister, W. Paul, J. Bonnet, and J. Benveniste. 1984. PAF-acether induced plasma exudation in rat skin is independent of platelets and neutrophils. Microcirc. Endothelium Lymphatics 1:107.
10. Hwang, S. B., C. L. Li, M. H. Lan, and T. Y. Shen. 1985. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guineapigs and rats and its inhibition by platelet-activating factor antagonists. Lab. Invest. 52:617.
11. 4 in rhesus monkeys. J. Lab. Clin. Med. 104:340.
12. Mazzoni, L., J. Morley, C. P. Page, and S. Sanjar. 1985. Induction of airway hyperreactivity by platelet activating factor in the guinea pig. J. Physiol. 365:107.
13. Cuss, F. M., C. M. S. Dixon, and P. J. Barnes. 1986. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2:189.
14. Chan-Yeung, M., S. Lam, H. Chan, K. S. Tse, and H. Salari. 1991. The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction. J. Allergy Clin. Immunol. 87:667.
15. Kurosawa, M., T. Yamashita, and F. Kurimoto. 1994. Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. Allergy 49:60.
16. Grandel, K. E., M. L. Wardlow, and R. S. Farr. 1985. Platelet activating factor in sputum of patients with asthma and COPD. J. Allergy Clin. Immunol. 7S:184.
17. Stenton, S. C., E. N. Court, W. P. Kingston, P. Goadby, C. A. Kelly, M. Duddridge, C. Ward, D. J. Hendrick, and E. H. Walters. 1990. Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur. Respir. J. 3:408.
18. Shirasaki, H., M. Nishikawa, I. M. Adcock, J. C. Mak, T. Sakamoto, T. Shimizu, and P. J. Barnes. 1994. Expression of platelet-activating factor receptor mRNA in human and guinea pig lung. Am. J. Respir. Cell Mol. Biol. 10:533.
19. 2 with a catalytic triad. J. Biol. Chem. 270:25481.
20. Tjoelker, L. W., C. Wilder, C. Eberhardt, D. M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. L. Trong, L. S. Cousens, G. A. Zimmerman, et al. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549.
21. Pheng, L. H., C. Francoeur, and M. Denis. 1995. The involvement of nitric oxide in a mouse model of adult respiratory distress syndrome. Inflammation 19:599.
22. Miwa, M., T. Miyake, T. Yamanaka, J. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumoto. 1988. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1483.
23. Stafforini, D. M., K. Satoh, D. L. Atkinson, L. W. Tjoelker, C. Eberhardt, H. Yoshida, T. Imaizumi, S. Takamatsu, G. A. Zimmerman, T. M. McIntyre, et al. 1996. Platelet-activating factor acetylhydrolase deficiency: a missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 97:2784.
24. Stafforini, D. M., T. Numao, A. Tsodikov, D. Vaitkus, T. Fukuda, N. Watanabe, N. Fueki, T. M. McIntyre, G. A. Zimmerman, S. Makino, and S. M. Prescott. 1999. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J. Clin. Invest. 103:989.
25. Henderson, W. R., Jr., D. B. Lewis, R. K. Albert, Y. Zhang, W. J. E. Lamm, G. K. S. Chiang, F. Jones, P. Eriksen, Y. Tien, M. Jonas, and E. Y. Chi. 1996. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184:1483.
26. Zhang, Y., W. J. E. Lamm, R. K. Albert, E. Y. Chi, W. R. Henderson, Jr., and D. B. Lewis. 1997. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am. J. Respir. Crit. Care Med. 155:661.
27. Amdur, M. O., and J. Mead. 1958. Mechanics of respiration in unanesthetized guinea pigs. Am. J. Physiol. 192:364.
28. Martin, T. R., N. P. Gerard, S. J. Galli, and J. M. Drazen. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64:2318.
29. Levitt, R. C., and W. Mitzner. 1988. Expression of airway hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice. FASEB J. 2:2605.
30. Su, M., E. Y. Chi, M. J. Bishop, and W. R. Henderson, Jr. 1993. Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs. Am. Rev. Respir. Dis. 147:448.
31. Troyer, H. 1980. Techniques of Histochemistry. Little, Brown, Boston, pp. 240-241.
32. Wardlaw, A. J., R. Moqbel, O. Cromwell, and A. B. Kay. 1986. Platelet-activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest. 78:1701.
33. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84:2068.
34. Walsh, G. M., A. Hartnell, A. J. Wardlaw, K. Kurihara, C. J. Sanderson, and A. B. Kay. 1990. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte inlegrin (CD11/18)-dependent manner. Immunology 71:258.
35. Morland, C. M., S. J. Wilson, S. T. Holgate, and W. R. Roche. 1992. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion. Am. J. Respir. Cell Mol. Biol. 6:557.
36. Okada, S., H. Kita, T. J. George, G. J. Gleich, and K. M. Leiferman. 1997. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Am. J. Respir. Cell Mol. Biol. 16:455.
37. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell sub-populations identified. J. Exp. Med. 184:1953.
38. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype and localization of dendritic cell subsets in Flt3-ligand treated mice. J. Immunol. 159:2222.
39. Moller, G. M., S. E. Overbeek, C. G. Van Helden, P. G. Mulder, D. S. Postma, and H. C. Hoogsteden. 1995. Increased numbers of DCs in the bronchial mucosa of atopic asthmatic patienls: downregulation by inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 151:A776.
40. Chvatchko, Y., M. H. Kosco-Vilbois, S. Herren, J. Lefort, and J.-Y. Bonnefoy. 1996. Germinal center formation and local immunoglobulin E (1gE) production in the lung after an airway antigenic challenge. J. Exp. Med. 184:2353.
41. Aubas, P., B. Cosso, P. Godard, F. B. Michel, and J. Clot. 1984. Decreased suppressor cell activity of alveolar macrophages in bronchial asthma. Am. Rev. Respir. Dig. 130:875.
42. Gosset, P., P. Lassalle, A. B. Tonnel, J. P. Dessaint, B. Wallaert, L. Prin, J. Pestel, and A. Capron. 1988. Production of an interleukin-1 inhibitory factor by human alveolar macrophages from normals and allergic asthmatic patients. Am. Rev. Respir. Dis. 138:40.
43. Steinberg, K. P., J. A. Milberg, T. R. Martin, R. J. Maunder, B. A. Cockrill, and L. D. Hudson. 1994. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150:113.
44. McDonald, R. J., E. M. Berger, and J. E. Repine. 1991. Alveolar macrophage antioxidants prevent hydrogen peroxide-mediated lung damage. Am. Rev. Respir. Dis. 143:1088.
45. Henson, P. M., G. L. Larsen, J. E. Henson, S. L. Newman, R. A. Musson, and C. C. Leslie. 1984. Resolution of pulmonary inflammation. Fed. Proc. 43:2799.
46. Newman, S. L., J. E. Henson, and P. M. Henson. 1982. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J. Exp. Med. 156:430.
47. Adler, K. B., J. E. Schwarz, W. H. Anderson, and A. F. Welton. 1987. Platelet-activating factor stimulates secretion of mucin by explants of rodent airways in organ culture. Exp. Lung Res. 13:25.
48. Lundgren, J. D., M. Kaliner, C. Logun, and J. H. Shelhamer. 1990. Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway. Agents Actions 30:329.
49. Rieves, R. D., J. Goff, T. Wu, P. Larivee, C. Logun, and J. H. Shelhamer. 1992. Airway epithelial cell mucin release: immunologic quantitation and response to platelet-activating factor. Am. J. Respir. Cell Mol. Biol. 6:158.
50. Chung, K. F., H. Aizawa, G. D. Leikauf, I. F. Ueki, T. W. Evans, and J. A. Nadel. 1986. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J. Pharmacol. Exp. Ther. 236:580.
51. Longphre, M., and S. R. Kleeberger. 1995. Susceptibility to platelet-activating factor-induced airway hyperreactivity and hyperpermeability: interstrain variation and genetic control. Am. J. Respir. Cell Mol. Biol. 13:586.
52. Nagase, T., S. Ishii, H. Katayama, Y. Fukuchi, Y. Ouchi, and T. Shimizu. 1997. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor: roles of thromboxanes and leukotrienes. Am. J. Respir. Crit. Care Med. 156:1621.
53. Christman, B. W., P. L. Lefferts, and J. R. Snapper. 1987. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep. Am. Rev. Respir. Dis. 135:1267.
54. Kaye, M. G., and L. J. Smith. 1990. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects. Am. Rev. Respir. Dis. 141:993.
55. Lai, C. K. W., J. R. Jenkins, R. Polosa, and S. T. Holgate. 1990. Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects. J. Appl. Plysiol. 68:919.
56. Spence, D. P. S., S. L. Johnston, P. M. A. Calverley, P. Dhillon, C. Higgins, E. Ramhamadany, S. Turner, A. Winning, J. Winter, and S. T. Holgate. 1994. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am. J. Respir. Crit. Care Med. 149:1142.
57. Rubin, A. H., L. J. Smith, and R. Patterson. 1987. The bronchoconstrictor properties of platelet-activating factor in humans. Am. Rev. Respir. Dis. 136:1145.
58. Chung, K. F., and P. J. Barnes. 1989. Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects. Thorax 44:108.
59. Freitag, A., R. M. Watson, G. Matsos, C. Eastwood, and P. M. O'Byrne. 1993. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. Thorax 48:594.
60. Kuitert, L. M., K. P. Hui, S. Uthayarkumar, W. Burke, A. C. Newland, S. Uden, and N. C. Barnes. 1993. Effect of fhe platelet-activating factor antagonist UK-74,505 on the early and late response to allergen. Am. Rev. Respir. Dis. 147:82.
61. Hozawa, S., Y. Haruta, S. Ishioka, and M. Yamakido. 1995. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am. J. Respir. Crit. Care Med. 152:1198.
62. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109.
63. Harnelmann, E., A. Oshiba, J. Loader, G. L. Larsen, G. Gleich, J. Lee, and E. W. Gelfand. 1997. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155:819.
64. 4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J. Clin. Invest. 100:3083.